Piramal Pharma Limited (PPLPHARMA.BO)
INR 260.3
(-1.68%)
INR 260.3
(-1.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 47.1 Billion INR | -16.44% |
| 2022 | 56.37 Billion INR | 36.56% |
| 2021 | 41.27 Billion INR | 2268.83% |
| 2020 | 1.74 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 46.43 Billion INR | 0.0% |
| 2023 FY | 47.1 Billion INR | -16.44% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 45.34 Billion INR | 0.0% |
| 2023 Q4 | 47.1 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 50.16 Billion INR | 0.0% |
| 2022 FY | 56.37 Billion INR | 36.56% |
| 2022 Q4 | 56.37 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 41.27 Billion INR | 0.0% |
| 2021 FY | 41.27 Billion INR | 2268.83% |
| 2020 FY | 1.74 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -13250.794% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -272431.389% |
| Sigachi Industries Limited | 1.43 Billion INR | -3192.628% |
| Bal Pharma Limited | 1.39 Billion INR | -3272.871% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -28237.585% |
| Medico Remedies Limited | 80.5 Million INR | -58408.397% |
| Lasa Supergenerics Limited | 220.76 Million INR | -21235.918% |
| Venus Remedies Limited | 413.3 Million INR | -11296.467% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -7602.633% |
| Alpa Laboratories Limited | 52.46 Million INR | -89677.185% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -641.132% |
| Shilpa Medicare Limited | 9.37 Billion INR | -402.477% |
| Aarti Drugs Limited | 5.64 Billion INR | -734.735% |
| Lupin Limited | 29.21 Billion INR | -61.209% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 29.145% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -485.695% |
| Windlas Biotech Limited | 36.41 Million INR | -129264.46% |
| Suven Life Sciences Limited | 7.09 Million INR | -663583.246% |
| Eris Lifesciences Limited | 27.81 Billion INR | -69.353% |
| Valiant Laboratories Limited | 767.08 Million INR | -6040.344% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -1147.196% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -365.661% |
| Ipca Laboratories Limited | 14.38 Billion INR | -227.467% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -4617.704% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | -43.88% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -1315.209% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -2173.546% |
| Laurus Labs Limited | 25.77 Billion INR | -82.749% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -6397.973% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | -17.11% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -817.874% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -282.651% |
| Unichem Laboratories Limited | 2.47 Billion INR | -1802.986% |
| Sequent Scientific Limited | 4.87 Billion INR | -865.804% |
| Novartis India Limited | 69.7 Million INR | -67477.618% |
| Wanbury Limited | 1.16 Billion INR | -3943.59% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -7146.801% |
| Wockhardt Limited | 23.56 Billion INR | -99.922% |
| Themis Medicare Limited | 957.92 Million INR | -4817.06% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -52580.461% |
| Jubilant Pharmova Limited | 36.64 Billion INR | -28.552% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -27367.693% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -135.273% |
| Divi's Laboratories Limited | 30 Million INR | -156905.333% |
| NATCO Pharma Limited | 3.71 Billion INR | -1168.901% |
| Gufic Biosciences Limited | 3.32 Billion INR | -1314.821% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -14277.778% |
| Ind-Swift Limited | 10.13 Billion INR | -364.515% |
| Procter & Gamble Health Limited | 95.6 Million INR | -49169.456% |
| FDC Limited | 205.18 Million INR | -22855.674% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -2335.078% |
| Granules India Limited | 13.15 Billion INR | -258.17% |
| Medicamen Biotech Limited | 308.17 Million INR | -15184.192% |
| Alkem Laboratories Limited | 14.18 Billion INR | -232.073% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -102334.866% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1073073.844% |
| Brooks Laboratories Limited | 56.41 Million INR | -83385.351% |
| Megasoft Limited | 1.47 Billion INR | -3103.166% |
| ZIM Laboratories Limited | 1.08 Billion INR | -4228.221% |
| Strides Pharma Science Limited | 25.16 Billion INR | -87.144% |
| Neuland Laboratories Limited | 953.89 Million INR | -4837.813% |
| Morepen Laboratories Limited | 289.99 Million INR | -16142.379% |
| Hikal Limited | 8.17 Billion INR | -476.11% |
| Indoco Remedies Limited | 6.71 Billion INR | -600.958% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -1551.239% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -14783.668% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -4682.252% |
| Hester Biosciences Limited | 2.44 Billion INR | -1827.408% |